LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma.
Cell Mol Gastroenterol Hepatol
; 10(4): 811-828, 2020.
Article
in En
| MEDLINE
| ID: mdl-32615164
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Drug Resistance, Neoplasm
/
Carcinoma, Pancreatic Ductal
/
Cytoskeletal Proteins
/
Deoxycytidine
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cell Mol Gastroenterol Hepatol
Year:
2020
Document type:
Article